SYNTAX score. Number & location of lesions. Dominance. Left Main. Calcification. 3 Vessel. Thrombus. Total Occlusion. Bifurcation.

Size: px
Start display at page:

Download "SYNTAX score. Number & location of lesions. Dominance. Left Main. Calcification. 3 Vessel. Thrombus. Total Occlusion. Bifurcation."

Transcription

1 PCI vs CABG for Multivessel Disease: Calculatio of Risk ad Log Term Outcome Pawel Buszma, MD, PhD, FESC, FACC Professor of Medicie, Medical Uiversity of Silesia, Katowice, Polad TCT AP 2010

2 Strategy qlocal Heart team (surgeo & itervetioal cardiologist) assessed each patiet i regards to: qpatiet s operative risk (EuroSCORE & Parsoet score, Clevelad score) qoperative risk scores predict perioperative ad i-hospital surgical risk of death or sever complicatios qcoroary lesio complexity (SYNTAX score) qsyntax score provides guidace o optimal revascularizatio strategies for patiets with high-risk lesios based o results of SYNTAX Study qpci risk score: risk of techical failure ad hemodyamic collapse qpredictio of log term outcome ( years) after PCI ad CABG

3 Assessemet of extet of coroary artery disease SYNTAX Score: Calcificatio Domiace Number & locatio of lesios Left Mai Thrombus SYNTAX score 3 Vessel Bifurcatio Total Occlusio Tortuosity EuroIterv 2005;1:

4 Sytax score vs 12/12 outcome

5 Logistic EuroScore Age Sex (per 5 years or part thereof over 60 years) 1 female Chroic pulmoary disease Extracardiac arteriopathy logterm use of brochodilators or steroids for lug disease 1 ay oe or more of the followig: claudicatio, carotid occlusio or >50% Extracardiac arteriopathy ay oe or more of the followig: claudicatio, carotid occlusio or >50% steosis, previous or plaed itervetio o the abdomial aorta,limb arteries or carotids 2 Neurological dysfuctio disease severely affectig ambulatio or day-to-day fuctioig 2 Previous cardiac surgery Serum creatiie Active edocarditis requirig opeig of the pericardium 3 >200m micromol/l preoperatively 2 patiet still uder atibiotic treatmet for edocarditis at the time of surgery 3 ay oe or more of the followig: vetricular tachycardia or fibrillatio or Critical preoperative state aborted sudde death, preoperative cardiac massage, preoperative vetilatio before arrival i the aaesthetic room,preoperative iotropic support, itraaortic balloo couterpulsatio or preoperative acute real failure (auria or oliguria<10 ml/hour) 3 Cardiac-related related factors Ustable agia 2 LV dysfuctio Score rest agia requirig iv itrates util arrival i the aaesthetic room moderate or LVEF30-50% 1 poor or LVEF <30 3 Recet myocardial ifarct Pulmoary hypertesio 2 Operatio-related related factors Emergecy 2 Other tha isolated CABG (<90 days) 2 Systolic PA pressure>60 mmhg Score carried out o referral before the begiig of the ext workig day major cardiac procedure other tha or i additio to CABG 2

6 EuroScore calculator: additive ad logistic

7 Euroscore - calculator

8 SYNTAX TRIAL: Predictors of CABG Variable 12 moth MACCE: Pre- procedure Odds Ratio [95% CI] P value COPD 2.45 [1.25, 4.80] Ustable Agia 1.88 [1.14, 3.09] 0.01 Moderate or Poor LVEF 1.98 [1.13, 3.47] 0.02 SYNTAX Score 0.97 [0.95, 1.00] 0.02 Race 0.33 [0.14, 0.82] 0.02 Emerget Revasc [1.08, 7.17] 0.03 Prior MI 0.57 [0.33, 0.99] Age 1.03 [1.00, 1.05] TAXUS Medically Treated Diabetes 2.07 [1.40, 3.05] <0.001 SYNTAX Score 1.02 [1.00, 1.04] 0.02 Age 1.02 [1.00, 1.04] 0.03

9 Sytax Trial Euroscore additive Sytax Score 1 year mortality 1 year MACE PCI RCT 3,8 28,4 4,3 17,8 CABG RCT 3,8 29,1 3,5 12,1 PCI Reg. 5,8 31,6 7,4 20,5 CABG Reg 3,8 35,5 2,5 8,8

10 Decisio diagram EuroScore High Risk PCI PCI??? (PCI vs Rx?) 5 Low Risk PCI PCI or CABG: LM = PCI 3vd ad DM = CABG CABG >33 Sytax Score

11 High risk populatio Acute coroary sydrome patiets LMCA disease Depressed LV fuctio Diabetes, Real Failure etc.

12 LE MANS Registry (=252)

13 LE MANS REGISTRY Results: ui ad multivariate aalysis with Odds Ratio for log term follow-up Age >60 y.o. LVEF<50% Stet diam.<3,8mm DES p=0,03 OR:2,48 (1,03-5,95 p=0,01 OR:3,25 (1,45-7,27) p=0,04 OR:2,48 (0,99-5,7) p=0,11 OR:0,53 (0,23-1,18) Euroscore>9 p=0,04 OR:2,48 (1,1-4,56) The Cox multivariate aalysis for idepedet risk factors showed that EF<50% decreased survival rate, while DES implatatio decreased ad stet diameter <3,8mm icreased the risk of MACCE.

14 ACS Registry PL-ACS ( pts i Polad) Substudy: revascularizatio for MVD i 3787 pts (Years ) 2009)

15 Results 30 day mortality p=0,1

16 PCI better tha CABG for MVCAD ad NST-ACS? 100% 98% 96% 94% 92% 90% 88% 86% 84% 82% 80% 78% 76% 74% 72% 70% Two years cumulative survival: PCI vs. CABG Time (days) CABG PCI

17 Sigle ad idepedet risk factors ifluecig log term mortality i ACS + MVCAD CABG* Male Ustable Agia NSTEMI Cardiogeic shock * Tobacco Hypertesio Dyslipidemia Diabetes Obesity Prior MI Prior CABG Prior PCI * Idepedet risk factor 0, Odds ratio

18 DES for ACS subaalysis of all comers studies AHP Registry

19 Sigle risk / beefit factors ifluecig 2 year mortality Age>65 Male Ustable agia NSTEMI STEMI Killip>1 Euroscore<7 BMI>27 Hypertesio DM Obesity Tobacco Hyperlipidemia Family History Creatiie>0,9 COPD prior MI prior PCI prior CABG 0,0316 0,3162 3, ,6228 Odds ratio

20 Sigle risk / beefit factors ifluecig 2 year mortality Sigle risk / beefit factors ifluecig two year mortality LVEF<50% MVD LM disease 2 d ge DES Cypher Biomatrix Edeavor Xiece Stet diam.<3,0 Resteotic lesio CTO predilatatio Complete revasc GPI 0,0316 0,3162 3, ,6228 Odds ratio

21 100% 100% 99% 99% 98% 98% 97% 97% 96% 96% 95% 95% 94% 94% 93% 93% 92% 92% 91% 91% 90% Cumulative survival: DES 1 st ge vs DES 2 d ge F-Cox p = 0, Time (days) DES 2d ge DES 1st ge

22 PCI scorig system to predict early ad log term outcome Cliical risk factors: SA/UA/NSTEMI/STEMI Killip class LV fuctio Biomarkers Risk of bleedig Atiplatelet pre-treatmet, bedside platelet reactivity Diabetes Mellitus, Real Failure, PAD Hyperlipidemia ad pre-treatmet with statis

23 PCI scorig system to predict early ad log term outcome Agiographic risk vessel CAD LMCA disease Sytax score! Peri- ad post PCI risk (residual risk) DES vs BMS No of stets Overlappig stets Appositio ad strut expasio, residual steosis (IVUS!) adge dissectio Prox/dist lesios, TIMI flow post PCI Complete revascularizatio Bleedig, MI

24 Algorhytm to predict outcome after PCI or CABG Based o data from the large registries ad radomized trials (PCI, CABG) a risk calculator should be desiged to predict the late outcome after PCI or CABG i a particular case!

25 Previous experiece Patiet Specific Predictios ad Comparisos for Patiets with Coroary Artery Disease. DC Naftel, EH Blackstoe, JW Kirkli Software ver.1.0, Summit Medical Systems JACC 1991;17: Circulatio 1991;83: (data icludig ca 6000 CABG ad 300 PCI pts)

26 The Cardiologist as a gatekeeper Is recascularizatio ecessary? Yes, if progostic or symptomatic idicatios Ca we perform PCI? Yes, if techically feasible at low periprocedural risk Ca we do it as good as the surgeos? Log term results? SYNTAX score, EUROSCORE, PCI/CABG calculator? Should I do it? Oly if the experiece i multivessel, complex

27 SYNTAX Score: guidig selectio of revascularizatio

28 Sytax Score Examples Left Mai Radomized Score 25 LM & 3VD Radomized Score 39 LM & 3VD Registry Score 50

29 Euroscore - calculator

30 100% Euroscore > 7 vs <7 99% 98% 97% 96% 95% F-Cox p = 0,01 94% 93% 92% 91% 90% Time (days) ES < 7 ES > 7

31 100% DM vs. o DM 99% 98% 97% F-Cox p = 0,02 96% 95% 94% 93% 92% Time (days) DM

32 MACCE at 12 Moths by SYNTAX Score Tercile All Terciles PCI Registry Cumulative Evet Rate (%) High (³33) Itermediate (23-32) 16.1% 16.1% Low (0-22) Moths Sice Allocatio 26.9% Kapla-Meier rates Per-protocol populatio

33 Overall MACCE to 12 Moths TAXUS RCT ad PCI Registry TAXUS RCT* (=903) PCI Reg (=192) Cumulative Evet Rate (%) % % Moths Sice Allocatio Evet Rate ± 1.5 SE * For descriptive purposes oly; o statistical comparisos doe Per-protocol populatio Kapla-Meier rates

MICHELANGELO: OASIS 5 Women s Substudy

MICHELANGELO: OASIS 5 Women s Substudy MICHELANGELO: OASIS 5 Wome s Substudy Dr. Eva Swah Departmet of Cardiology, Heart Cetre, Uiversity Hospital, Liköpig Swede Disclosure Fuded by Saofi-Sythelabo, Orgao NV ad GSK Dr. Swah has o coflicts of

More information

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 Igor F. Palacios, MD Director of Interventional Cardiology Professor of Medicine Massachusetts

More information

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,

More information

PCI vs. CABG From BARI to Syntax, Is The Game Over?

PCI vs. CABG From BARI to Syntax, Is The Game Over? PCI vs. CABG From BARI to Syntax, Is The Game Over? Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea PCI vs CABG Multi-Vessel Disease

More information

COMMENT DEFINIR UN PLURITRONCULAIRE. Didier Carrié CHU Toulouse Rangueil

COMMENT DEFINIR UN PLURITRONCULAIRE. Didier Carrié CHU Toulouse Rangueil COMMENT DEFINIR UN PLURITRONCULAIRE VISION ANGIOGRAHIQUE DU PLURITRONCULAIRE Didier Carrié CHU Toulouse Rangueil Congrès GRCI 03 Décembre 2010 Pôle Cardiovasculaire et Métabolique Avec quel œil je regarde

More information

Left Main Intervention: Where are we in 2015?

Left Main Intervention: Where are we in 2015? Left Main Intervention: Where are we in 2015? David A. Cox, MD FSCAI Director, Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown, PA Fall Fellows Course Laa

More information

high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy

high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy What to do with patients with high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin San Giovanni Battista Hospital Turin / Italy Who are the patients with high SYNTAX

More information

Left Main Intervention: Will it become standard of care?

Left Main Intervention: Will it become standard of care? Left Main Intervention: Will it become standard of care? David Cox, MD FSCAI, FACC Director, Interventional Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown,

More information

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease

More information

The SYNTAX-LE MANS Study

The SYNTAX-LE MANS Study The SYNTAX-LE MANS Study Synergy Between PCI with TAXUS Express and Cardiac Surgery: Late (15-month) Left Main Angiographic Substudy A. Pieter Kappetein, MD, PhD Erasmus MC, Rotterdam, NL SYNTAX-LE MANS

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

Abstract Aims: To evaluate the angiographic and clinical outcome of patients undergoing paclitaxel-eluting stent CLINICAL RESEARCH

Abstract Aims: To evaluate the angiographic and clinical outcome of patients undergoing paclitaxel-eluting stent CLINICAL RESEARCH CLINICAL RESEARCH DOI: 10.4244/EIJV7I6A110 Early ad log-term results of uprotected left mai coroary artery steosis with paclitaxel-elutig stets: the FRIEND (Frech multicetre registry for stetig of uprotected

More information

Reconciling the Results of the Randomized Trials

Reconciling the Results of the Randomized Trials Management of Stable Angina in Multivessel Disease: Reconciling the Results of the Randomized Trials Eric A. Cohen MD, FRCPC Schulich Heart Centre Sunnybrook Health Sciences Centre Toronto ON ACC Rockies

More information

IVUS vs FFR Debate: IVUS-Guided PCI

IVUS vs FFR Debate: IVUS-Guided PCI IVUS vs FFR Debate: IVUS-Guided PCI Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Disclosure Statement of Financial Interest Within the past 12 months, I have had a financial interest/arrangement

More information

INFORMATION FOR YOU AND YOUR FAMILY. Melody Transcatheter Pulmonary Valve Therapy

INFORMATION FOR YOU AND YOUR FAMILY. Melody Transcatheter Pulmonary Valve Therapy INFORMATION FOR YOU AND YOUR FAMILY Melody Trascatheter Pulmoary Valve Therapy This booklet is provided to help you ad your loved oes lear more about Melody Trascatheter Pulmoary Valve (TPV) Therapy. Please

More information

Mise à Jour sur le traitement du Pluritronculaire Philippe Généreux, MD

Mise à Jour sur le traitement du Pluritronculaire Philippe Généreux, MD Mise à Jour sur le traitement du Pluritronculaire Philippe Généreux, MD Columbia University Medical Center and The Cardiovascular Research Foundation, New York, USA Hôpital du Sacré-Coeur de Montréal,

More information

Left Main and Bifurcation Summit I. Lessons from European LM Studies

Left Main and Bifurcation Summit I. Lessons from European LM Studies Left Main and Bifurcation Summit I Apr 29 8.56-9.09 Lessons from European LM Studies Alaide Chieffo, MD S. Raffaele Hospital, Milan, Italy Nothing to disclose regarding this presentation Lesion Location

More information

Diabetic Patients: Current Evidence of Revascularization

Diabetic Patients: Current Evidence of Revascularization Diabetic Patients: Current Evidence of Revascularization Alexandra J. Lansky, MD Yale University School of Medicine University College of London The Problem with Diabetic Patients Endothelial dysfunction

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

Patients in whom PCI is preferred over CABG _ Aleksander Ernst Clinical Hospital Center Zagreb University of Zagreb School of Medicine Zagreb, CROATIA

Patients in whom PCI is preferred over CABG _ Aleksander Ernst Clinical Hospital Center Zagreb University of Zagreb School of Medicine Zagreb, CROATIA 3rd Dubrovnik Cardiology Highlights An ESC Update Programme in Cardiology 26.09.-29.09.2013, Hotel Excelsior, Dubrovnik, Croatia Patients in whom PCI is preferred over CABG _ Aleksander Ernst Clinical

More information

Quick Reference to Transthoracic Echo Screening

Quick Reference to Transthoracic Echo Screening Quick Referece to Trasthoracic Echo Screeig Idicatio: The MitraClip Clip Delivery System is idicated for the percutaeous reductio of sigificat symptomatic mitral regurgitatio (MR 3+) due to primary abormality

More information

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,

More information

Diagnostic, Technical and Medical

Diagnostic, Technical and Medical Diagnostic, Technical and Medical Approaches to Reduce CABG Related Stroke Pieter Kappetein, Michael Mack, M.D. Dept Thoracic Surgery, Rotterdam, The Netherlands Baylor Healthcare System Dallas, TX Background

More information

Rationale for Percutaneous Revascularization ESC 2011

Rationale for Percutaneous Revascularization ESC 2011 Rationale for Percutaneous Revascularization Marie Claude Morice, Massy FR MD, FESC, FACC ESC 2011 Paris Villepinte - 27-31 August, 2011 Massy, France Potential conflicts of interest I have the following

More information

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures

More information

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016 Controversies in Coronary Revascularization Atlanta CCU April 15, 2016 Habib Samady MD FACC FSCAI Professor of Medicine Director, Interventional Cardiology, Emory University Director, Cardiac Catheterization

More information

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX Maquet, Inc.,- unpaid consultant Cordis, Inc.,- unpaid consultant Boston Scientific, Inc.,- travel expenses paid for Syntax

More information

Controversies in Cardiac Surgery

Controversies in Cardiac Surgery Controversies in Cardiac Surgery 3 years after SYNTAX : Percutaneous Coronary Intervention for Multivessel / Left main stem Coronary artery disease Pro ESC Congress 2010, 28 August 1 September Stockholm

More information

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical

More information

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX Boston Scientific, Inc.- Syntax Trial Steering Committee Member- travel expenses paid by trial sponsor Maquet, Inc.- unpaid

More information

CABG vs PCI: What do the Guidelines Say?

CABG vs PCI: What do the Guidelines Say? AATS International Cardiovascular Symposium: Sao Paolo 2017 CABG vs PCI: What do the Guidelines Say? David P Taggart MD PhD FRCS FESC Professor of Cardiovascular Surgery, University of Oxford Conflicts

More information

R&M Solutions

R&M Solutions PCI with DES versus CABG & syntax score Dr. Mohamed Sobhy, MD, FACC, FESC Professor of Cardiology, Alexandria University, Egypt Head of Cardiology Department President of Egyptian Society of Cardiology

More information

Unprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy

Unprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy Unprotected Left Main Stenting: Patient Selection and Recent Experience Alaide Chieffo S. Raffaele Hospital, Milan, Italy Class IIa (Level B) AHA/ACC 2005 Guidelines Left Main CAD The use of PCI for pts

More information

Surgery Grand Rounds

Surgery Grand Rounds Surgery Grand Rounds Coronary Artery Bypass Grafting versus Coronary Artery Stenting Charles Ted Lord, R1 Coronary Artery Disease Stenosis of epicardial vessels Metabolic & hematologic Statistics 500,000

More information

Management of cardiovascular disease - coronary interventions -

Management of cardiovascular disease - coronary interventions - Master Classes in Preventive Cardiology I Management of diabetes in patients with CVD European Heart House Management of cardiovascular disease - coronary interventions - Francesco Cosentino MD, PhD, FESC

More information

Clinical Considerations for CTO

Clinical Considerations for CTO 38 RCTs Clinical Considerations for CTO 18,000 pts Revascularization Whom to treat, Who derives benefit and What can we achieve? David E. Kandzari, MD FACC, FSCAI Director, Interventional Cardiology Research

More information

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Prof. Ran Kornowski, MD, FESC, FACC Director - Division of Interventional Cardiology Rabin Medical Center and Tel Aviv University,

More information

Le# Main Interven-on: When Is It Appropriate. Femi Philip, MD Assistant Professor Of Medicine UC Davis

Le# Main Interven-on: When Is It Appropriate. Femi Philip, MD Assistant Professor Of Medicine UC Davis Le# Main Interven-on: When Is It Appropriate Femi Philip, MD Assistant Professor Of Medicine UC Davis Nil Disclosures Outline What is the LMCA? Should we revascularize severe LMCA disease? What revascularizacon

More information

Coronary interventions

Coronary interventions Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan none DECLARATION OF CONFLICT OF INTEREST CHF

More information

Drug Eluting Stents: Bifurcation and Left Main Approach

Drug Eluting Stents: Bifurcation and Left Main Approach TCT Asia 2006 Drug Eluting Stents: Bifurcation and Left Main Approach Eberhard Grube MD FACC, FSCAI Heart Center,, Germany Stanford University, School of Medicine, CA, USA DES in High Risk Lesions TAXUS

More information

Off-Pump Coronary Artery Bypass (OPCAB) surgery is

Off-Pump Coronary Artery Bypass (OPCAB) surgery is Off-Pump Coroary Artery Bypass () Surgery Reduces Risk-Stratified Morbidity ad Mortality: A Uited Kigdom Multi-Ceter Comparative Aalysis of Early Cliical Outcome Sharif Al-Ruzzeh, FRCS; Gareth Ambler,

More information

ACE-27 with Dr. Piccirillo from Washington University St. Louis. August 18, 2009

ACE-27 with Dr. Piccirillo from Washington University St. Louis. August 18, 2009 ACE-27 with Dr. Piccirillo from Washigto Uiversity St. Louis August 18, 2009 Itroductio Patiets with cacer ofte have other diseases, illesses, or coditios i additio to their idex cacer These other coditios

More information

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS Coronary Physiology In The Cathlab FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS Educational Training Program ESC European Heart House april 7th 9th 2011 Nico H.J.Pijls, MD, PhD Catharina Hospital,

More information

Abstract Aims: The current study reports clinical outcomes at three year follow-up of the LEADERS clinical trial CLINICAL RESEARCH

Abstract Aims: The current study reports clinical outcomes at three year follow-up of the LEADERS clinical trial CLINICAL RESEARCH CLINICAL RESEARCH The three year follow-up of the radomised all-comers trial of a biodegradable polymer biolimus-elutig stet versus permaet polymer sirolimus-elutig stet (LEADERS) Joaa Wykrzykowska 1,

More information

Lessons learned From The National PCI Registry

Lessons learned From The National PCI Registry Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients

More information

When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER

When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER ICPS, Massy ICV-GVM La Roseraie, Aubervilliers Hôpital FOCH, Suresnes Disclosure Statement of Financial

More information

BIOFLOW-III an all comers registry with a Sirolimus Eluting Stent: Presentation of 1-Year TLF Data in patients with complex lesions

BIOFLOW-III an all comers registry with a Sirolimus Eluting Stent: Presentation of 1-Year TLF Data in patients with complex lesions BIOFLOW-III an all comers registry with a Sirolimus Eluting Stent: Presentation of 1-Year TLF Data in patients with complex lesions Johannes Waltenberger, MD, F.E.S.C. Uniklinik Münster Münster, Germany

More information

FFR in Multivessel Disease

FFR in Multivessel Disease FFR in Multivessel Disease April, 26 2013 Coronary Physiology in the Catheterization Laboratory Location: European Heart House, Nice, France Pim A.L. Tonino, MD, PhD Hartcentrum, Eindhoven, the Netherlands

More information

Fractional Flow Reserve and the Results of the FAME Study

Fractional Flow Reserve and the Results of the FAME Study Imaging and Physiology Summit Seoul, Korea November 21 st, 2009 Fractional Flow Reserve and the Results of the FAME Study William F. Fearon, M.D. Assistant Professor Division of Cardiovascular Medicine

More information

PTCA 1979: : I

PTCA 1979: : I The SYNTAX Message is Clear: CABG is Preferred in Complex MVD Angioplasty Summit TCTAP 2012 Seoul, Korea April 2012 David R. Holmes, MD Mayo Clinic Rochester, MN Presenter Disclosure Information David

More information

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017

Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Asian AMI Registry Session The 17 th Joint Meeting of Coronary Revascularization (JCR 2017) Busan, Korea Dec 8 th 2017 Trends of acute myocardial infarction in Korea from the experience of Korea Acute

More information

Important LM bifurcation studies update

Important LM bifurcation studies update 8 th European Bifurcation Club 12-13 October 2012 - Barcelona Important LM bifurcation studies update I Sheiban E-mail: isheiban@yahoo.com Unprotected LM Percutaneous Revascularization What is important

More information

Alex versus Xience Registry Preliminary report

Alex versus Xience Registry Preliminary report Interventional Cardiology Network Alex versus Xience Preliminary report Mariusz Gąsior 1,2, Marek Gierlotka 1, Lech Poloński 1,2 1 3rd Department of Cardiology, Medical University of Silesia Centre tor

More information

What do the guidelines say?

What do the guidelines say? Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European

More information

Modified Early Warning Score Effect in the ICU Patient Population

Modified Early Warning Score Effect in the ICU Patient Population Lehigh Valley Health Network LVHN Scholarly Works Patiet Care Services / Nursig Modified Early Warig Score Effect i the ICU Patiet Populatio Ae Rabert RN, DHA, CCRN, NE-BC Lehigh Valley Health Network,

More information

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study Five-Year Results in the French Subset René Koning, MD On behalf of the SYNTAX investigators Three-year

More information

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011 Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011 Prof. Dr. Volkmar Falk Klinik für Herz- und Gefäßchirurgie, Universitätsspital Zürich, Schweiz In 2004 headlines were

More information

Left Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France

Left Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France Left Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France Background on LM stenosis 5% of patients undergoing angiography Of the myocardium 80% Bifurcation

More information

Primary: To assess the change on the subject s quality of life between diagnosis and the first 3 months of treatment.

Primary: To assess the change on the subject s quality of life between diagnosis and the first 3 months of treatment. Study No.: AVO112760 Title: A Observatioal Study To Assess The Burde Of Illess I Prostate Cacer Patiets With Low To Moderate Risk Of Progressio Ratioale: Little data are available o the burde of illess

More information

ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΣΤΟ ΔΙΑΒΗΤΙΚΟ ΑΣΘΕΝΗ

ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΣΤΟ ΔΙΑΒΗΤΙΚΟ ΑΣΘΕΝΗ ΑΓΓΕΙΟΠΛΑΣΤΙΚΗ ΣΤΟ ΔΙΑΒΗΤΙΚΟ ΑΣΘΕΝΗ Νίκος Μεζίλης MD, FESC Κλινική Άγιος Λουκάς Why diabetes is associated with restenosis endothelial dysfunction metabolic alterations accelerated platelet deposition

More information

RESTENOSIS Facing up to the problem

RESTENOSIS Facing up to the problem RESTENOSIS Facing up to the problem Petr Kala University Hospital Brno Czech Republic ESC 2011, Paris Disclosure Scientific Advisory Boards or Education presentations fee Abbott, Boston Scientific, Cordis

More information

Approach to Multi Vessel disease with STEMI

Approach to Multi Vessel disease with STEMI Approach to Multi Vessel disease with STEMI MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION Dr. Thomas Alexander, M.D; D.M; F.A.C.C. Senior Consultant and Interventional Cardiologist Kovai Medical Centre

More information

Clinical Considerations for CTO Revascularization

Clinical Considerations for CTO Revascularization Clinical Considerations for CTO Revascularization Whom to treat, Who derives benefit and What can we achieve? David E. Kandzari, MD, FACC, FSCAI Chief Medical Officer Cordis Cardiology Johnson & Johnson

More information

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors

More information

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

Fractional Flow Reserve: Review of the latest data

Fractional Flow Reserve: Review of the latest data Fractional Flow Reserve: Review of the latest data Michalis Hamilos, MD, PhD, FESC University Hospital of Heraklion Fractional Flow Reserve (FFR) Coronary angiography does not always tell the truth Most

More information

Assessing Myocardium at Risk: Applying SYNTAX

Assessing Myocardium at Risk: Applying SYNTAX Assessing Myocardium at Risk: Applying SYNTAX Farouc Jaffer MD PhD FSCAI FACC FAHA Associate Professor of Medicine, Harvard Medical School Director, CAD Program and Chronic Total Occlusion PCI Program

More information

Management of High-Risk CAD : Surgeons Perspective

Management of High-Risk CAD : Surgeons Perspective Management of High-Risk CAD : Surgeons Perspective Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan Conflict : Cardiac Surgeon! High Risk CABG 77 year old with prior large anterior

More information

PCI for LMCA lesions A Review of latest guidelines and relevant evidence

PCI for LMCA lesions A Review of latest guidelines and relevant evidence HCS Working Group Seminars Met Hotel, Thursday 14 th February 2013 PCI for LMCA lesions A Review of latest guidelines and relevant evidence Vassilis Spanos Interventional Cardiologist, As. Director 3 rd

More information

FFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford

FFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea FFR-Guided PCI William F. Fearon, M.D. Associate Professor Division of Cardiovascular Medicine University Medical Center Disclosure Statement

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy.

Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy. Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy. GENNARO SARDELLA, MD, FACC,FESC; MASSIMO MANCONE,

More information

Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe?

Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe? Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe? T. Lefèvre,, Massy, France Background Despite continuous improvement, PTCA of chronic total occlusion remains a real technical challenge.

More information

Percutaneous Intervention of Unprotected Left Main Disease

Percutaneous Intervention of Unprotected Left Main Disease Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected

More information

PCI Update Qesaria 2009

PCI Update Qesaria 2009 PCI Update Qesaria 2009 Amit Segev Interventional Cardiology Chaim Outline Primary PCI Non-ST elevation ACS Multi-vessel disease Hemodynamic assessment of borderline lesions - FFR Stable AP Non-coronary

More information

Fractional Flow Reserve (FFR) Measurement System Value Dossier

Fractional Flow Reserve (FFR) Measurement System Value Dossier PressureWire Fractioal Flow Reserve (FFR) Measuremet System Value Dossier The St. Jude Medical PressureWire Measuremet System for Fractioal Flow Reserve (FFR) Measuremet i Coroary Artery Steosis The PressureWire

More information

COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands

COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands TCTAP 2010 Seoul, Korea Disclosures Research Foundation of the Cardiology Department has received unrestricted research grants from:

More information

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol

More information

Abstract Aims: Smaller studies have previously shown promising results after Tryton Side Branch Stent (Tryton CLINICAL RESEARCH

Abstract Aims: Smaller studies have previously shown promising results after Tryton Side Branch Stent (Tryton CLINICAL RESEARCH CLINICAL RESEARCH Six-moth ad oe-year cliical outcomes after placemet of a dedicated coroary bifurcatio stet: a patiet-level pooled aalysis of eight registry studies Maik J. Grudeke 1, MD; Solomo Asgedom

More information

Most Patients with Elective Left Main Disease. Farrel Hellig

Most Patients with Elective Left Main Disease. Farrel Hellig Most Patients with Elective Left Main Disease Should be Treated with PCI! Farrel Hellig Sunnnghill and Sunward Park Hospitals Johannesburg South Africa Everything that can be invented has been invented

More information

Preoperative Cardiac Risk Assessment: Approach & Guidelines

Preoperative Cardiac Risk Assessment: Approach & Guidelines Preoperative Cardiac Risk Assessment: Approach & Guidelines By, Liam Morris, MD., FACC (02/03/18) CPG : Clinical Practice Guidelines GDMT : Guidelines Directed Medical Therapy GWC : Guideline Writing Committee

More information

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National

More information

Inspiron Stent. Clinical Research Program. Pedro A. Lemos MD PhD. Heart Institute InCor University of Sao Paulo Medical School Sao Paulo Brazil

Inspiron Stent. Clinical Research Program. Pedro A. Lemos MD PhD. Heart Institute InCor University of Sao Paulo Medical School Sao Paulo Brazil Stent Clinical Research Program Pedro A. Lemos MD PhD Heart Institute InCor University of Sao Paulo Medical School Sao Paulo Brazil All faculty disclosures are available on the CRF Events App and online

More information

Management of High-Risk Coronary Artery Disease

Management of High-Risk Coronary Artery Disease Management of High-Risk Coronary Artery Disease Jeffrey J. Popma, MD Director, Interventional Cardiology Clinical Services Beth Israel Deaconess Medical Center Associate Professor of Medicine Harvard Medical

More information

Perspective of LM stenting with Current registry and Randomized Clinical Data

Perspective of LM stenting with Current registry and Randomized Clinical Data Asian Pacific TCT Perspective of LM stenting with Current registry and Randomized Clinical Data Patrick W. Serruys MD PhD Yoshinobu Onuma MD Seung-Jung Park MD, PhD 14:48-15:00, 2009 Symposium Arena, Level

More information

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João

More information

Unprotected left main coronary stenting with a second generation drug-eluting stent. One-year clinical follow-up of the LeMaX pilot study.

Unprotected left main coronary stenting with a second generation drug-eluting stent. One-year clinical follow-up of the LeMaX pilot study. Unprotected left main coronary stenting with a second generation drug-eluting stent. One-year clinical follow-up of the LeMaX pilot study. N. Boudou, N. Salvatella, N. Dumonteil, M.C. Morice, O. Darremont,

More information

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Introduction/Background. Research Team.

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Introduction/Background. Research Team. Research Team Early Ambulatio Reduces the Risk of Veous Thromboembolism After Total Kee Replacemet Marily Szekedi, PhD, RN Baafsheh Sadeghi, MD, PhD, School of Medicie, Uiversity of Califoria Davis Patrick

More information

Cardiogenic Shock. Carlos Cafri,, MD

Cardiogenic Shock. Carlos Cafri,, MD Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and

More information

Cindy L. Grines MD FACC FSCAI

Cindy L. Grines MD FACC FSCAI Cindy L. Grines MD FACC FSCAI Hofstra Northwell School of Medicine Chair, Cardiology Academic Chief of Cardiology, Northwell Health North Shore University Hospital, Manhasset NY Multivessel Disease in

More information

Medical Rx vs PCI vs CABG

Medical Rx vs PCI vs CABG Medical Rx vs PCI vs CABG S. Hinan Ahmed, MD Associate Professor: Cardiology and Cardiothoracic Surgery Program Director: Interventional Fellowship Program Assoc Editor: Cath and Cardiovasc Intervention

More information

Benefit of Performing PCI Based on FFR

Benefit of Performing PCI Based on FFR Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided

More information

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries ANGIOPLASY SUMMIT 007 TCT ASIA PACIFIC Seoul, Korea: 5-7 7 April 007 15 min Plenary Session: State-of of-the-art Lectures The problem is exaggerated: Data from Real World Registries Antonio Colombo Centro

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

Disclosures. Theodore A. Bass MD, FSCAI. The following relationships exist related to this presentation. None

Disclosures. Theodore A. Bass MD, FSCAI. The following relationships exist related to this presentation. None SCAI Fellows Course December 10, 2013 Disclosures Theodore A. Bass MD, FSCAI The following relationships exist related to this presentation None Current Controversies on DAPT in PCI Which drug? When to

More information

Myocardial revascularisation in multivessel disease: The value of risks scores

Myocardial revascularisation in multivessel disease: The value of risks scores Myocardial revascularisation in multivessel disease: The value of risks scores ESC 2012 Marie Claude Morice, Darren Mylotte, Institut cardiovasculaire Paria Sud, Massy,France Declaration of conflict of

More information

Radiation Exposure During Percutaneous Coronary Interventions and Coronary Angiograms Performed by the Radial Compared With the Femoral Route

Radiation Exposure During Percutaneous Coronary Interventions and Coronary Angiograms Performed by the Radial Compared With the Femoral Route JACC: CARDIOVASCULAR INTERVENTIONS VOL. 5, NO. 7, 2012 2012 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jci.2012.03.020

More information

DEMAND RESULTS. TRUST ENDURANT.

DEMAND RESULTS. TRUST ENDURANT. DEMAND RESULTS. TRUST ENDURANT. Edurat ll AAA Stet System Edurat IIs AAA Stet System THE ENDURANT II SYSTEM FAMILY OF PRODUCTS Icludes Edurat II, Edurat II AUI ad Edurat IIs stets. Desiged to meet a wide

More information

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital Complex PCI: Multivessel Disease George W. Vetrovec, MD. Kimmerling Chair of Cardiology VCU Pauley Heart Center Virginia

More information